Predictive Factors of Response to Cyclosporine in Steroid-Refractory Ulcerative Colitis

被引:76
作者
Cacheux, Wulfran [1 ]
Seksik, Philippe [1 ]
Lemann, Marc [2 ]
Marteau, Philippe [3 ]
Nion-Larmurier, Isabelle [1 ]
Afchain, Pauline [1 ]
Daniel, Fady [4 ,5 ]
Beaugerie, Laurent [1 ]
Cosnes, Jacques [1 ]
机构
[1] St Antoine Hosp, AP HP, Dept Gastroenterol, F-75571 Paris 12, France
[2] Hop St Louis, Paris, France
[3] Lariboisiere Hosp, Paris, France
[4] Univ Paris 06, Paris, France
[5] Georges Pompidou Hosp, Paris, France
关键词
D O I
10.1111/j.1572-0241.2007.01653.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
OBJECTIVES: Cyclosporine is an effective rescue therapy in steroid-refractory ulcerative colitis (UC) and may avoid immediate colectomy. However, the individual's response to cyclosporine is poorly predictable. The aim of this study was to identify predictive factors of the response to cyclosporine in steroid-refractory UC. METHODS: One hundred thirty-five patients with steroid-refractory UC, admitted consecutively between 1992 and 2004, were included. Data were collected on the first day of the cyclosporine therapy. Colonoscopy was performed within 2 days preceding or following the cyclosporine treatment in 118 patients for assessing the presence of severe endoscopic lesions. RESULTS: The actuarial rate of colectomy was 0.45 at 6 months. Cox analysis in the whole population selected three predictive criteria of colectomy: body temperature > 37.5 degrees C (adjusted hazard ratio = 1.94, 95% confidence interval 1.51-2.49), heart rate > 90 bpm (1.86, 1.45-2.38), and C-reactive protein (CRP) > 45 mg/L (1.70, 1.34-2.16). In the 118 patients who underwent colonoscopy, the presence of severe endoscopic lesions was an independent predictive factor of colectomy (2.38, 1.80-3.14). Colonoscopy was decisive and changed the therapeutic decision in patients with one or two criteria: 71% of the patients with severe endoscopic lesions were colectomized versus 17% of the patients without severe endoscopic lesions (P < 0.001). Finally, the clinical, biological, and endoscopic criteria allowed the classification of the patients into two different groups (80% vs 20% colectomy at 6 months). CONCLUSION: In patients with steroid-refractory UC, the combination of simple criteria is useful to predict the response to cyclosporine. Colonoscopy is crucial in patients with intermediate clinical and biological severity. (Am J Gastroenterol 2008;103:637-642).
引用
收藏
页码:637 / 642
页数:6
相关论文
共 28 条
[1]
Long-term outcome of treatment with intravenous cyclosporin in patients with severe ulcerative colitis [J].
Arts, J ;
D'Haens, G ;
Zeegers, M ;
Van Assche, G ;
Hiele, M ;
D'Hoore, A ;
Penninckx, F ;
Vermeire, S ;
Rutgeerts, P .
INFLAMMATORY BOWEL DISEASES, 2004, 10 (02) :73-78
[2]
Ciclosporin use in acute ulcerative colitis: a long-term experience [J].
Campbell, S ;
Travis, S ;
Jewell, D .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2005, 17 (01) :79-84
[3]
Intravenous cyclosporine in attacks of ulcerative colitis - Short-term and long-term responses [J].
Carbonnel, F ;
Boruchowicz, A ;
Duclos, B ;
Soule, JC ;
Lerebours, E ;
Lemann, M ;
Belaiche, J ;
Colombel, JF ;
Cosnes, J ;
Gendre, JP .
DIGESTIVE DISEASES AND SCIENCES, 1996, 41 (12) :2471-2476
[4]
COLONOSCOPY OF ACUTE COLITIS - A SAFE AND RELIABLE TOOL FOR ASSESSMENT OF SEVERITY [J].
CARBONNEL, F ;
LAVERGNE, A ;
LEMANN, M ;
BITOUN, A ;
VALLEUR, P ;
HAUTEFEUILLE, P ;
GALIAN, A ;
MODIGLIANI, R ;
RAMBAUD, JC .
DIGESTIVE DISEASES AND SCIENCES, 1994, 39 (07) :1550-1557
[5]
Carbonnel F, 2000, ALIMENT PHARM THERAP, V14, P273
[6]
Cohen RD, 1999, AM J GASTROENTEROL, V94, P1587
[7]
Cottone M, 2001, AM J GASTROENTEROL, V96, P773, DOI 10.1111/j.1572-0241.2001.03620.x
[8]
Multidrug resistance gene-1 polymorphisms and resistance to cyclosporine a in patients with steroid resistant ulcerative colitis [J].
Daniel, Fady ;
Loriot, Marie-Anne ;
Seksik, Philippe ;
Cosnes, Jacques ;
Gornet, Jean-Marc ;
Lemann, Marc ;
Fein, Francine ;
Vernier-Massouille, Gwenola ;
De Vos, Martine ;
Boureille, Arnaud ;
Treton, Xavier ;
Flourie, Bernard ;
Roblin, Xavier ;
Louis, Edouard ;
Zerbib, Frank ;
Beaune, Philippe ;
Marteau, Philippe .
INFLAMMATORY BOWEL DISEASES, 2007, 13 (01) :19-23
[9]
COURSE AND PROGNOSIS OF ULCERATIVE COLITIS [J].
EDWARDS, FC ;
TRUELOVE, SC .
GUT, 1963, 4 (04) :299-+
[10]
Infliximab for refractory ulcerative colitis or indeterminate colitis: an open-label multicentre study [J].
Gornet, JM ;
Couve, S ;
Hassani, Z ;
Delchier, JC ;
Marteau, P ;
Cosnes, J ;
Bouhnik, Y ;
Dupas, JL ;
Modigliani, R ;
Taillard, F ;
Lemann, M .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 18 (02) :175-181